Chinese Heparin Supplier Posts Strong Trading Debut

Friday, May 7, 2010 - 00:01 in Mathematics & Economics

The shares of Shenzhen Hepalink Pharmaceutical rose 18.3 percent, valuing the company at about $10 billion.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net